Literature DB >> 25934712

Correction: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR.

.   

Abstract

Entities:  

Year:  2015        PMID： 25934712     DOI： 10.1158/0008-5472.CAN-15-0822

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  1 in total

1.  Mutational profiling of non-small-cell lung cancer patients resistant to first-generation EGFR tyrosine kinase inhibitors using next generation sequencing.

Authors:  Ying Jin; Yang Shao; Xun Shi; Guangyuan Lou; Yiping Zhang; Xue Wu; Xiaoling Tong; Xinmin Yu
Journal:  Oncotarget       Date:  2016-09-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.